CYTOGENETIC RESPONSE, MOLECULAR RESPONSE AND OUTCOME OF ELDERLY PH+ CML PATIENTS WITH STABLE COMPLETE CYTOGENETIC RESPONSE AFTER 4-YEARS OF INTERMITTENT TREATMENT WITH IMATINIB (INTERIM)